BIOMAT Database Logo BIOMAT Database Logo

Excretion of hydroflumethiazide in bile and urine of man. 1979

O Brørs, and J F Haffner, and S Jacobsen

Biliary and urinary excretion of hydroflumethiazide (HFT) and its metabolite, 2,4-disulfamyl-5-trifluoromethylaniline (DTA), was investigated in 5 otherwise healthy patients with a T-drain in the common bile duct after cholecystectomy and choledochotomy. After a single oral dose of HFT 302--453 micromoles, a mean of 0.051% (range 0.028--0.075) of the dose was excreted in bile and 34.9% (range 23.7--45.4) in urine during the first 6 hours after administration. Biliary excretion appeared to be of minor importance in the elimination of HFT by man. DTA could not be detected in bile.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006857 Hydroflumethiazide A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p822) Diucardin,Trifluoromethylhydrothiazide
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

O Brørs, and J F Haffner, and S Jacobsen
[Excretion of drugs in bile in man].
January 1980, Die Pharmazie,
O Brørs, and J F Haffner, and S Jacobsen
Spectrofluorometric determination of hydroflumethiazide in plasma and urine.
August 1976, Journal of pharmaceutical sciences,
O Brørs, and J F Haffner, and S Jacobsen
Urine volume and catecholamine excretion in man.
January 1961, Acta cardiologica,
O Brørs, and J F Haffner, and S Jacobsen
[Diagrams of excretion of bile in man].
November 1955, Nederlands tijdschrift voor geneeskunde,
O Brørs, and J F Haffner, and S Jacobsen
Distribution of elimination of hydroflumethiazide in man.
September 1979, European journal of clinical pharmacology,
O Brørs, and J F Haffner, and S Jacobsen
Pharmacokinetics of orally administered hydroflumethiazide in man.
January 1977, Journal of clinical pharmacology,
O Brørs, and J F Haffner, and S Jacobsen
Coproporphyrin I and 3 excretion in bile and urine.
November 1972, The Journal of clinical investigation,
O Brørs, and J F Haffner, and S Jacobsen
Effect of parathormone on calcium excretion in bile and urine.
January 1965, Surgical forum,
O Brørs, and J F Haffner, and S Jacobsen
RADIOACTIVE IRON AND ITS EXCRETION IN URINE, BILE, AND FECES.
October 1939, The Journal of experimental medicine,
O Brørs, and J F Haffner, and S Jacobsen
Excretion of propylthiouracil and its metabolites in rat bile and urine.
June 1974, Endocrinology,
Copied contents to your clipboard!